National formulary

At the heart of our plasma protein and related products program is the national formulary. We manage the formulary of products on behalf of provincial and territorial ministries of health (not including Quebec).

Products listed on the formulary are accessible to clinicians in Canada for use in caring for their patients. Approximately 50 products are listed on the formulary. All products provided through our formulary program are funded by the provincial and territorial health ministries at no cost for patients, whether the treatment is administered in a hospital or clinic or in a patient’s home.

Product Selection Process

How do products get on the formulary?

Any new product needs to be licensed by Health Canada before it will be considered for the national formulary. New products can be added to the formulary in one of two ways, either through Canadian Blood Services’ RFP process or through a product review process involving Canadian Blood Services and the Canadian Agency for Drugs and Technologies in Health (CADTH) and must be approved by the provincial and territorial ministries of health (excluding Quebec).

*The product selection process for the national plasma protein and related products formulary is under review. Please contact PPRPFormularyprogram@blood.ca for any questions.